Article
The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
Mutagenesis - 1 Jul 2010
Chu Haiyan, Wang Meilin, Wang Miaomiao, Gu Dongying, Wu Dongmei, Zhang Zhizhong, Tang Jialin, Zhang Zhengdong
Abstract excerpt
Myeloperoxidase (MPO) is an endogenous oxidant enzyme that generates reactive oxygen species and plays an important role in the aetiology of cancer. The MPO -463G>A polymorphism influences MPO transcription and has been implicated in cancer risk. However, results from published studies on the association between the MPO -463G>A polymorphism and risk of cancer are conflicting. To derive a more precise estimation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
